Test guide
Abbott Architect SARS-CoV-2 IgM Serology Assay
A chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum and plasma on the Abbott ARCHITECT i system. The presence of IgM antibodies may be associated with recent infection or may assist with the evaluation of disease course.
What it is for
Source: National Cancer Institute, NCI Thesaurus 26.09d, C180707. Unmodified NCI definition, CC BY 4.0. Source identity and classification checked automatically on 2026-10-20.
Limitations
Terminology reference for a laboratory procedure. The source definition does not establish routine clinical availability, validated specimen types, reference intervals, product authorization or suitability for an individual. Consult the performing laboratory for its validated method and interpretation.
Also known as
- Abbott Architect SARS-CoV-2 IgM Serology Assay
Reviewed products
Curated product links for this test are still under editorial review. Meanwhile, browse the product directory or request a supplier match below.